Module 1 - Administrative information application form
The name of the applicant should be included in the field ‘Applicant’, and its address in the field ‘Address’. Person signing the application form should have a letter of authorisation for communication/signing on behalf of the applicant (to be attached in annex 5.4). 1. Type of application 1.1. This application concerns 1.1.1.
Download Module 1 - Administrative information application form
Information
Domain:
Source:
Link to this page:
Documents from same domain
Q12 Step 2b Technical and regulatory …
www.ema.europa.euICH guideline Q12 on technical and regulatory considerations for pharmaceutical product lifecycle management EMA/CHMP/ICH/804273/2017 Page 3/36
Guideline on good pharmacovigilance practices …
www.ema.europa.eu9 December 2013 . EMA/816292/2011 Rev 1* Guideline on good pharmacovigilance practices (GVP) Module VII – Periodic safety update report (Rev 1)
Guideline on good pharmacovigilance practices (GVP)
www.ema.europa.euGuideline on good pharmacovigilance practices (GVP) – Module IX (Rev 1) EMA/827661/2011 Rev 1 Page 2/25
Guideline on good pharmacovigilance practices …
www.ema.europa.euGuideline on good pharmacovigilance practices (GVP) – Module VIII (Rev 3) EMA/813938/2011 Rev 3 Page 2/28
Guideline for good clinical practice E6(R2)
www.ema.europa.euGuideline for good clinical practice E6(R2) EMA/CHMP/ICH/135/1995 Page 2/70 Document History First Codification History Date New Codification
Guideline for good clinical practice E6(R2)
www.ema.europa.euGuideline for good clinical practice E6(R2) EMA/CHMP/ICH/135/1995 Page 2/75 10 Document History 11 First Codification History Date New Codification November
Guideline on good pharmacovigilance practices …
www.ema.europa.euharmful physical or psychological effects [DIR 2001/83/EC Art 1(1 6)]. 74 Adverse event (AE); synonym: Adverse experience 75 Any untoward medical occurrence in a patient or clinical- trial subject administered a medicinal product
European Medicines Agency
www.ema.europa.eu© EMEA 2006 2 SPECIFICATIONS: TEST PROCEDURES AND ACCEPTANCE CRITERIA FOR BIOTECHNOLOGICAL/BIOLOGICAL PRODUCTS ICH Harmonised Tripartite Guideline
products1/traditional herbal medicinal products
www.ema.europa.euThere is no expectation that existing herbal medicinal products on the market will be affected by this guideline, with the exception of traditional herbal medicinal products for human use that were already
Q7 Q&A - good manufacturing practice for active ...
www.ema.europa.euICH guideline Q7 on good manufacturing practice for active pharmaceutical ingredients – questions and answers EMA/CHMP/ICH/468930/2015 Page 2/37
Related documents
Community Infrastructure Levy (CIL) Form 1 - CIL ...
ecab.planningportal.co.ukForm 1 - CIL Additional Information . Please note: ... It is the applicant’s responsibility to provide evidence to the effect that buildings were in a ... you or the relevant parties need to complete ‘Form 2: Assumption of Liability’ (PDF). 4. If you intend to claim:
APPLICANT INFORMATION (person with disability)
www.dmv.virginia.gov, submit this form with applicable fees. Placard or replacement ID card will be mailed to you within approximately 15 days. Only one placard may be issued to a customer. For disabled parking license plates, submit this form, a completed License Plate Application (VSA 10) and applicable fees. For placard and/or license plates,
Request to Change Applicant Biographic Information Form …
www.ecfmg.orgRequest to Change Applicant Biographic Information Form 182 . INSTRUCTIONS: Complete the applicable sections in ink, referring to the instructions that accompany this form. (Must be completed.) 2 (Must be completed.) 3 . Name Change (Check the box and complete this section ONLY if you are requesting a name change.) 4 (Must be completed.) 5 ...
RELEASE OF EMPLOYMENT HISTORY LKE INSTRUCTIONS
www.in.govinformation via the LKE website: • Use only the attached form. No other forms will be accepted or completed. Do not submit non-DWD forms. • Ask applicants to provide all previously used names during employment on the IDWD approved release form. • Confirm the form is complete, legible, and there are no corrected errors on the release form ...
Section I – Applicant Information This Section Must be Typed
www.mwaa.comMar 10, 2021 · applicant sign and date the statement in order to be issued an Identification Badge: “The information I have provided is true, complete and correct to the best of my knowledge and belief and is provided in good faith. I understand that knowing and willful false statement can be punished by fine or imprisonment or both.
Information for submission of Form TMSM-01
www.state.nj.usPlease note: Only one type (Trademark or Servicemark) can be checked on the form. Multiple Classifications can be used on the same form as long as they fall under the same mark type. Item 5 – Applicant Information: Must list complete name and address (a and b). Must check one box on . line (c). Complete lines (d) and/or (e) if applicable.
PURPOSE APPLICANT/VEHICLE INFORMATION
www.tn.govo Receipts for all parts replaced as indicated on this form. The receipts must show the year, make, and identification number of the vehicle from which they were taken. The receipts must show the complete name and mailing address of the applicant and/or rebuilder and seller(s). If the parts used were
TRANSMITTAL FOR POWER OF ATTORNEY TO ONE OR MORE ...
www.uspto.govApplicant Name (if Applicant is a juristic entity) NOTE: This form must be signed in accordance with 37 CFR 1.33. See 37 CFR 1.4(d) for signature requirements and certifications. If more than one applicant, use multiple forms. *Total of _____ forms are submitted. This collection of information is required by 37 CFR 1.131, 1.32, and 1.33.